Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients

17 Jan 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to interferon and immune responses
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26943956
DOI: 10.1016/j.jneuroim.2016.01.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patientsPMID 26943956Read ↗

Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?Semantic proximity Read ↗

Gene-expression signatures: biomarkers toward diagnosing multiple sclerosisSemantic proximity Read ↗

Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.Semantic proximity Read ↗

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients’ individual gene expression in peripheral bloodSemantic proximity Read ↗

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitisSemantic proximity Read ↗

Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple SclerosisSemantic proximity Read ↗

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.Semantic proximity Read ↗

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between PatientsSemantic proximity Read ↗

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosisSemantic proximity Read ↗

Long-Term Genome-Wide Blood RNA Expression Profiles Yield Novel Molecular Response Candidates for IFN-β-1b Treatment in Relapsing Remitting MSSemantic proximity Read ↗

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patientsSemantic proximity Read ↗

IFN-beta pharmacogenomics in multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.